Background. Lung fibrosis is a sequela of COVID-19 among patients with severe pneumonia.
Idiopathic pulmonary fibrosis and lung fibrosis due to COVID-19 may share many similar …

Background: There are limited data on home mechanical ventilation (HMV) in developing
countries. This study aimed to describe the patient characteristics, feasibility, and outcomes of …

Background High-flow nasal cannula (HFNC) therapy is commonly used to treat acute
respiratory failure in patients with COVID-19 pneumonia. However, predictors of successful …

Background. High-flow nasal cannula (HFNC) therapy is a common respiratory support in
patients with COVID-19 pneumonia. Predictive tools for the evaluation of successful weaning …

Background Air pollution has become a serious environmental and health issue in several
countries. This condition leads to respiratory diseases, particularly asthma and chronic …

➢ Asthma exacerbation within 3 months➢ On systemic steroid treatment 3 months➢ On biologic
treatment➢ 10-pack-year smoking history➢ Comorbidity eg, AF, chronic heart diseases, …

Weaning failure in mechanically ventilated chronic obstructive pulmonary disease (COPD)
patients is a major concern in clinical practice. Rapid shallow breathing index (RSBI), a well-…

BACKGROUND: Asthma Control Test (ACT), the Asthma Control Questionnaire (ACQ), the
Asthma Treatment Assessment Questionnaire (ATAQ), the Asthma Control Scoring System (…

Background: Pleural fluid adenosine deaminase (ADAPF) is a diagnostic test for diagnosing
the early tuberculous pleuritis (TBP). However, cutoff values vary widely in many studies. …

Introduction: Patients with mild coronavirus 2019 disease (COVID-19) are usually treated in
an outpatient setting. Pulmonary functions in this setting have not been observed. This study …